Detalhe da pesquisa
1.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Br J Haematol
; 167(1): 121-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992281
2.
Renal function in patients with ß-thalassaemia major: a long-term follow-up study.
Nephrol Dial Transplant
; 27(9): 3547-51, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22695832
3.
Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.
Blood Cells Mol Dis
; 46(4): 294-9, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21402483
4.
Evidence for a proatherogenic biochemical phenotype in beta thalassemia minor and intermedia.
Acta Haematol
; 126(2): 87-94, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576933
5.
Case report: thalassemia intermedia patient with hypertension non-responsive to combined medical treatment.
Pediatr Endocrinol Rev
; 8 Suppl 2: 337-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21705990
6.
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone.
Blood Cells Mol Dis
; 45(2): 136-9, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20678715